Lipum AB (OSTO:LIPUM) Ending Cash Position : kr6.63 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Lipum AB Ending Cash Position?

Lipum AB's Ending Cash Position for the quarter that ended in Dec. 2024 was kr6.63 Mil.

Lipum AB's quarterly Ending Cash Position declined from Jun. 2024 (kr20.13 Mil) to Sep. 2024 (kr12.87 Mil) and declined from Sep. 2024 (kr12.87 Mil) to Dec. 2024 (kr6.63 Mil).

Lipum AB's annual Ending Cash Position declined from Dec. 2022 (kr32.84 Mil) to Dec. 2023 (kr10.23 Mil) and declined from Dec. 2023 (kr10.23 Mil) to Dec. 2024 (kr6.61 Mil).

Lipum AB Ending Cash Position Historical Data

The historical data trend for Lipum AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipum AB Ending Cash Position Chart

Lipum AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

4.44

47.05

32.84

10.23

6.61

Lipum AB Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial														10.23	1.47	20.13	12.87	6.63

Lipum AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Lipum AB's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10.226	+	-3.619
	=	6.61

Lipum AB's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	22.848	+	-16.216
	=	6.63

Lipum AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Lipum AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipum AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tvistevagen 48 C, Umea, SWE, 907 36

Website

https://www.lipum.se

Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.

Lipum AB Headlines

No Headlines